zydus - Robuta Search

https://www.livemint.com/news/india/zydus-cadila-gets-dcgi-nod-to-repurpose-hepatitis-drug-to-treat-covid19-11619191268039.html Zydus gets DCGI nod for hepatitis drug to treat covid Apr 23, 2021 - The drug was originally used in treatment against hepatitis B and C, and is administered in a single dose subcutaneous regimen zydus gets nod hepatitis drug https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-seeks-dcgi-approval-for-its-oral-pill-to-treat-anemia-due-to-ckd/87869471 Kidney Diseases: Zydus Cadila seeks DCGI approval for its oral pill to treat anemia due to CKD,... Kidney Diseases: Zydus Cadila is seeking approval for Desidustat an oral pill alternative for the treatment of anemia due to Chronic Kidney Disease (CKD) in... https://pharma.economictimes.indiatimes.com/news/drug-approvals-and-launches/zydus-lifesciences-gets-usfda-nod-to-produce-prostrate-cancer-drug/113898132 Zydus Lifesciences gets USFDA nod to produce prostrate cancer drug, ETPharma Zydus Lifesciences: The company has received tentative approval from the US Food and Drug Administration (USFDA) to manufacture Enzalutamide tablets (40 mg and... zydus lifesciences prostrate cancer gets usfda nod https://health.economictimes.indiatimes.com/news/pharma/cadila-arm-completes-sale-of-animal-health-business-for-rs-2921-crore/84439792 Zydus Animal Health And Investment: Cadila arm completes sale of animal health business for Rs... In May this year, Zydus Animal Health and Investment has entered into definitive pacts for sale of its animal healthcare established markets undertaking to... https://economictimes.indiatimes.com/markets/stocks/news/gmm-pfaudler-zydus-among-17-stocks-that-mfs-picked-with-both-hands-in-q2/articleshow/78633364.cms Top stocks to buy today: GMM Pfaudler, Zydus among 17 stocks that MFs picked with both hands in Q2... Initial shareholding data of India Inc available so far suggests the top MF pick during the quarter was Zydus Wellness, where fund managers raised stake by 515... https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-american-health-regulators-approval-to-market-mineral-supplement/78183277 Zydus Cadila gets American health regulator's approval to market mineral supplement, ETHealthworld Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Potassium Chloride extended release tablets in the... https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-launches-generic-prostate-cancer-drug-at-nearly-70-less-price-in-india/75639941 Zydus Cadila launches generic prostate cancer drug at nearly 70% less price in India, ETHealthworld "Our aim is to make a preferred choice of therapy like Obynx available and more accessible to people suffering from cancer. Bridging these unmet gaps comes... https://ec2-3-139-13-63.us-east-2.compute.amazonaws.com/produtos/topiramato-100mg-60com-c1-zydus/ TOPIRAMATO 100MG 60COM C1* ZYDUS - Riomed topiramato zydus https://www.business-standard.com/amp/content/press-releases-ani/zydus-wellness-glucon-d-s-energy-ka-gola-energizes-thousands-of-children-across-india-125062500728_1.html Zydus Wellness' Glucon-D's 'Energy Ka Gola' energizes thousands of children across India Mumbai (Maharashtra) [India], June 25: As Indian cities battled sweltering heatwaves this summer, Zydus Wellness' Glucon-D, India's most trusted glucose-based... https://manufacturing.economictimes.indiatimes.com/news/life-sciences/zydus-acquires-us-biologics-manufacturing-facilities/121610075 Zydus acquires US biologics manufacturing facilities, ETManufacturing The deal gives Zydus control of biologics manufacturing units in Emeryville and Berkeley, California, providing immediate access to advanced development and... manufacturing facilities zydus acquires biologics https://health.economictimes.indiatimes.com/news/pharma/financial-performance/indias-zydus-lifesciences-q1-profit-beats-estimates-on-strong-us-demand/112399600 India's Zydus Lifesciences Q1 profit beats estimates on strong US demand, ETHealthworld Zydus Lifesciences: The company's consolidated net profit jumped nearly 31 per cent year-on-year to 14.2 billion rupees ($169.2 million) in the quarter ended... https://pharma.economictimes.indiatimes.com/news/drug-approvals-and-launches/zydus-receives-fda-approval-for-celecoxib-a-non-steroidal-painkiller/122511298 Zydus Lifesciences: Zydus Receives FDA Approval for Celecoxib, a Non-Steroidal Painkiller, ETPharma Zydus Lifesciences has announced that its non-steroidal anti-inflammatory drug, Celecoxib, has received final approval from the U.S. FDA. The generic version... zydus lifesciences fda approval https://health.economictimes.indiatimes.com/tag/zydus+hospital+ahmedabad Zydus hospital ahmedabad - Latest zydus hospital ahmedabad , Information & Updates - Health -ET... ETHealthworld.com brings latest zydus hospital ahmedabad news, views and updates from all top sources for the Indian Health industry. latest information zydus hospital ahmedabad updates https://manufacturing.economictimes.indiatimes.com/news/life-sciences/zydus-lifesciences-gets-usfda-nod-for-generic-schizophrenia-treatment-drug/114122375 Zydus Lifesciences gets USFDA nod for generic schizophrenia treatment drug, ETManufacturing The approval by the US Food and Drug Administration (USFDA) is for Paliperidone extended-release tablets of strengths 1.5 mg, 3 mg, 6 mg, and 9 mg, Zydus... zydus lifesciences schizophrenia treatment gets usfda nod https://health.economictimes.indiatimes.com/news/pharma/zydus-gets-us-fda-nod-to-market-ointment-for-skin-disorder/99764614 Zydus Lifesciences: Zydus gets US FDA nod to market ointment for skin disorder, ETHealthworld Zydus Lifesciences: Metronidazole is an antibiotic used on the skin to treat a certain skin disorder -- rosacea, a type of adult acne. The drug will be... https://www.livemint.com/zydus-lifesciences/bonus/companyid-s0003150 Zydus Lifesciences Bonus: Zydus Lifesciences Bonus Shares, Bonus Issue, Upcoming Zydus Lifesciences... Zydus Lifesciences Bonus: Find out Zydus Lifesciences Bonus Shares and Upcoming Bonus Issues. Stay Informed and Maximize Your Investments with Our Trusted... zydus lifesciences bonus shares issue upcoming https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/zydus-lifesciences-new-drug-application-for-desidustat-accepted-in-china/109532996 Zydus Lifesciences' new drug application for Desidustat accepted in China, ETHealthworld Discovered and developed by Zydus, Desidustat is being marketed by the group in India under the brand name Oxemia. CMS International Development and Management... new drug application zydus lifesciences in china https://www.archdaily.com/998290/zydus-headquarters-morphogenesis Zydus Headquarters / Morphogenesis | ArchDaily zydus headquarters morphogenesis archdaily https://manufacturing.economictimes.indiatimes.com/tag/zydus+jarod+plant Zydus jarod plant - Latest zydus jarod plant , Information & Updates - Manufacturing -ET... ETManufacturing.in brings latest zydus jarod plant news, views and updates from all top sources for the Indian Manufacturing industry. latest information zydus jarod plant updates https://health.economictimes.indiatimes.com/news/pharma/zydus-acquires-rights-to-market-monoferric-injection-in-indianepal-from-pharmacosmos-a/s-of-denmark/94094843 Zydus acquires rights to market MonoFerric injection in India,Nepal from Pharmacosmos A/S of... The MonoFerric iron isomaltoside 1,000 solutions for injection/infusion, is a rapid, single dose IV iron (up to 20 mg/kg body weight) developed to reduce the... https://health.economictimes.indiatimes.com/news/pharma/financial-performance/zydus-wellness-ltd-records-20-per-cent-net-sales-growth-in-q1/112236848 Zydus Wellness Ltd records 20 per cent net sales growth in Q1, ETHealthworld Zydus Wellness Ltd: The company registered growth in EBIDTA of 33.3 per cent y-o-y basis to Rs 1,553 million. Net profit for the quarter grew by 33.8 per cent... https://www.cafc.uscourts.gov/7-20-2017-16-1962-otsuka-pharmaceutical-co-v-zydus-pharmaceuticals-usa-rule-36-judgment-16-1962-rule_36_judgment-7-17-2017-1/ 16-1962: OTSUKA PHARMACEUTICAL CO. v. ZYDUS PHARMACEUTICALS USA [RULE 36 JUDGMENT], Nonprecedential... Jul 20, 2017 - Opinions/Orders posted: OTSUKA PHARMACEUTICAL CO. v. ZYDUS PHARMACEUTICALS USA [RULE 36 JUDGMENT](pdf) Appeal Number: 16-1962 Origin: DCT Nonprecedential To... https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-tentative-nod-from-usfda-to-market-cancer-drug/84614124 Zydus Cadila gets tentative nod from USFDA to market cancer drug, ETHealthworld The company has received tentative approval from the United States Food and Drug Administration (USFDA) to market Ibrutinib tablets, in the strengths of 140... zydus cadila https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-tentative-usfda-nod-to-market-lung-cancer-treatment-drug/83201464 Us Food And Drug Administration: Zydus Cadila gets tentative USFDA nod to market lung cancer... The company has received tentative approval from the US Food and Drug Administration (USFDA) to market Osimertinib tablets in the strengths of 40 mg and 80 mg,... food and drug administration https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-says-positive-results-from-phase-2-studies-of-covid-19-drug-desidustat-in-mexico/80446372 Covid Vaccine: Zydus Cadila says 'positive results' from phase 2 studies of Covid-19 drug... Covid Vaccine: In June 2020, Zydus Cadila had received approval from Mexico's regulatory authority Cofepris to test one of its lead research candidate... https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-unit-recalls-7248-bottles-of-oxybutynin-chloride-tablets-in-us/articleshow/104398305.cms Zydus unit recalls 7,248 bottles of Oxybutynin Chloride tablets in US - The Economic Times New Jersey-based Zydus Pharmaceuticals (USA) Inc. is recalling the affected lot due to "Failed Dissolution Specifications", the USFDA stated. The lot was... https://hr.economictimes.indiatimes.com/tag/zydus+cadila+healthcare+limited Zydus cadila healthcare limited - Latest zydus cadila healthcare limited , Information & Updates -... ETHRWorld.com brings latest zydus cadila healthcare limited news, views and updates from all top sources for the Indian HR industry. zydus cadila latest information healthcare limited updates https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/zydus-lifesciences-limited-685224-08292024?ref=merionwest.com Zydus Lifesciences Limited - 685224 - 08/29/2024 | FDA CGMP/Finished Pharmaceuticals/Adulterated zydus lifesciences limited fda https://pharma.economictimes.indiatimes.com/news/pharma-industry/zydus-and-glenmark-ceos-appointed-as-ipa-leaders/124293359 IPA New Leadership: Zydus and Glenmark CEOs appointed as IPA leaders, ETPharma IPA New Leadership: Zydus Lifesciences and Glenmark CEOs appointed as the new President and Vice President of IPA, leading the Indian Pharmaceutical Alliance... new leadership ipa zydus https://store.hbr.org/product/zydus-wellness-nutralite-s-marketing-twist/W19065?searchid=0&search_query=seal+market%3Fpage%3D14%3Fpage%3D17%3Fpage%3D19 Zydus Wellness: Nutralite's Marketing Twist Buy books, tools, case studies, and articles on leadership, strategy, innovation, and other business and management topics zydus wellness nutralite marketing twist https://health.economictimes.indiatimes.com/news/pharma/zydus-lifesciences-gets-tentative-nod-from-usfda-for-generic-breast-cancer-drug/101347770 Zydus Lifesciences gets tentative nod from USFDA for generic breast cancer drug, ETHealthworld Zydus Lifesciences: The drug is used to treat a certain type of breast cancer. It works by slowing or stopping the growth of cancer cells. The product will be... https://www.business-standard.com/amp/markets/capital-market-news/zydus-lifesciences-receives-usfda-tentative-approval-for-diroximel-fumarate-delayed-release-capsules-124071000698_1.html Zydus Lifesciences receives USFDA tentative approval for Diroximel Fumarate Delayed-Release... Zydus Lifesciences has received tentative approval from the United States Food and Drug Administration (USFDA) to market Diroximel Fumarate Delayed-Release... zydus lifesciences receives usfda tentative https://health.economictimes.indiatimes.com/news/pharma/zydus-receives-final-usfda-approval-for-bortezomib-injection/91313976 Zydus receives final USFDA approval for Bortezomib Injection, ETHealthworld Usfda: Bortezomib for injection is used to treat certain types of cancer, such as multiple myeloma and mantle cell lymphoma zydus receives final usfda approval https://www.business-standard.com/amp/industry/news/sun-pharma-zydus-recall-medicines-in-us-over-quality-concerns-usfda-125031600461_1.html Sun Pharma, Zydus recall medicines in US over quality concerns: USFDA | Industry News - Business... Sun Pharma and Zydus Pharmaceuticals are recalling products in the US market due to manufacturing issues, according to the US Food and Drug Administration... https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-usfda-nod-for-manufacturing-doxycycline-injection-at-vadodara/76996737 Zydus Cadila gets USFDA nod for manufacturing Doxycycline Injection at Vadodara, ETHealthworld Doxycycline Injection is used to treat or prevent bacterial infections, including pneumonia and other respiratory tract infections. zydus cadila for manufacturing https://www.business-standard.com/amp/markets/capital-market-news/stock-alert-vodafone-idea-avas-financers-zydus-life-medplus-health-jio-financial-services-125061900148_1.html Stock Alert: Vodafone Idea, Avas Financers, Zydus Life, Medplus Health, Jio Financial Services |... https://health.economictimes.indiatimes.com/tag/zydus+lifesciences Zydus lifesciences - Latest zydus lifesciences , Information & Updates - Health -ET HealthWorld ETHealthworld.com brings latest zydus lifesciences news, views and updates from all top sources for the Indian Health industry. zydus lifesciences latest information updates health et https://www.zyduslife.com/ Leading Global Pharmaceutical Company in India - Zydus group - Zydus Zydus Group, a leading Indian pharma company, offers global healthcare solutions from formulations and APIs to animal health and wellness products. global pharmaceutical company in india leading zydus group https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-launches-indias-cheapest-remdesivir-version-at-rs-2800-per-100-mg-vial/77520875 Zydus Cadila launches India's cheapest remdesivir version at Rs 2,800 per 100 mg vial, ETHealthworld Zydus is the fifth company to launch a copy of the antiviral in India after privately held Hetero Labs Ltd, Cipla, Mylan NV and Jubilant Life Sciences Ltd.... https://pharma.economictimes.indiatimes.com/news/regulatory-update/fda-fast-track-designation-for-zydus-usnoflast-a-breakthrough-in-als-treatment/121482671 FDA Fast Track Designation for Zydus' Usnoflast: A Breakthrough in ALS Treatment, ETPharma Zydus Lifesciences secures FDA Fast Track designation for Usnoflast, its innovative treatment for amyotrophic lateral sclerosis (ALS), highlighting the urgency... fast track designation https://health.economictimes.indiatimes.com/news/industry/we-will-be-focusing-on-a-three-pronged-strategy-to-drive-growth-says-zydus-wellness/78091810 We will be focusing on a three-pronged strategy to drive growth, says Zydus Wellness, ETHealthworld As a part of the strategy, the company would accelerate growth of core brands with innovations to focus on portfolio diversification and expansion with an aim... https://www.zyduswellness.com/ Zydus Wellness zydus wellness https://forbusiness.snapchat.com/success-stories/zydus-wellness Zydus Wellness Success Story | Snapchat For Business Snapchat helped Zydus Wellness reach 10 million Snapchatters for the launch of the latest product from Everyuth Naturals. zydus wellness success story snapchat business https://www.business-standard.com/article/current-affairs/zydus-covid-19-vaccine-doses-may-be-out-soon-for-adolescents-govt-121062700664_1.html Zydus Covid-19 vaccine doses may be out soon for adolescents: Govt | Coronavirus Latest News -... Says 1.35 bn doses will be available between Aug-Dec; 160 mn doses are expected between May and July https://health.economictimes.indiatimes.com/news/pharma/zydus-lifesciences-receives-final-usfda-approval-for-pemetrexed-a-chemotherapy-drug/91810543 Zydus Lifesciences receives final USFDA approval for Pemetrexed a chemotherapy drug, ETHealthworld Pemetrexed is used to treat certain types of cancers, such as lung cancer and mesothelioma. It is a chemotherapy drug that works by slowing or stopping the... zydus lifesciences https://health.economictimes.indiatimes.com/news/pharma/zydus-lifesciences-receives-usfda-approval-for-famotidine-tablets/92034155 Zydus Lifesciences receives USFDA approval for Famotidine tablets, ETHealthworld Famotidine tablets are used to prevent and treat heartburn and other symptoms caused by excessive acid in the stomach (acid indigestion). zydus lifesciences receives usfda approval famotidine https://zyduswellnessinstitute.com/ Food Science and Nutrition - Zydus Wellness Institute May 24, 2023 - Zydus Wellness Institute is an educational institute that focuses on Food Science and Nutrition. Our aim is to support healthcare and the scientific community. food science and nutrition zydus wellness institute https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-tentative-usfda-nod-to-market-anti-cancer-drug/78291575 Zydus Cadila gets tentative USFDA nod to market anti-cancer drug, ETHealthworld Drug firm Zydus Cadila on Thursday said it has received tentative approval from the US health regulator to market anti-cancer drug Palbociclib Capsules. zydus cadila https://pharma.economictimes.indiatimes.com/tag/zydus+pharmaceuticals+recall Zydus pharmaceuticals recall - Latest zydus pharmaceuticals recall , Information & Updates - Pharma... ETPharma.com brings latest zydus pharmaceuticals recall news, views and updates from all top sources for the Indian Pharma industry. latest information zydus pharmaceuticals recall updates https://pharma.economictimes.indiatimes.com/tag/zydus+lifesciences Zydus lifesciences - Latest zydus lifesciences , Information & Updates - Pharma -ETPharma ETPharma.com brings latest zydus lifesciences news, views and updates from all top sources for the Indian Pharma industry. zydus lifesciences latest information updates pharma https://www.zydusinfra.com/ Home - Zydus Infrastructure zydus infrastructure https://health.economictimes.indiatimes.com/news/pharma/drug-approvals-launches/zydus-gets-usfda-nod-for-generic-product/100852710 Zydus Lifesciences: Zydus gets USFDA nod for generic product, ETHealthworld The product will be manufactured at the group's formulation manufacturing facility in Moraiya, Ahmedabad, Zydus Lifesciences and As per IQVIA MAT April 2023... zydus lifesciences generic product gets usfda nod https://timesofindia.indiatimes.com/india/covid-vaccine-for-kids-above-12-likely-by-july-end-or-august-govt/articleshow/83892012.cms Zydus Covid vaccine for kids above 12 likely to be available by July-end or August: Govt | India... India News: The government on Sunday said that Covid vaccination of children in the 12-18 age group may start by the end of July or in August. Trial for Zydus... https://manufacturing.economictimes.indiatimes.com/tag/zydus+lifesciences Zydus lifesciences - Latest zydus lifesciences , Information & Updates - Manufacturing -ET... ETManufacturing.in brings latest zydus lifesciences news, views and updates from all top sources for the Indian Manufacturing industry. zydus lifesciences latest information updates manufacturing et https://brandequity.economictimes.indiatimes.com/news/research/advertising/zydus-wellness-shifts-indian-snacking-habits-with-millet-wafer-protein-bars-in-new-ad/126784559 RiteBite Max Protein Launch: Zydus Wellness Revolutionizes Snacking with New Millet Wafer Protein... RiteBite Max Protein Launch: Zydus Wellness has launched a new range of Millet Wafer Protein Bars under its RiteBite Max Protein brand, merging indulgent... ritebite max protein zydus wellness https://health.economictimes.indiatimes.com/news/hospitals/zydus-hospitals-medtronic-collaborate-to-launch-ai-based-stroke-care-network-in-gujarat/97985144 Zydus Hospitals, Medtronic collaborate to launch AI-based stroke care network in Gujarat,... Zydus Hospitals: The partnership will serve the people of peripheral Gujarat by helping them deal with stroke as a disease effectively. The hub and spoke... https://health.economictimes.indiatimes.com/news/pharma/zydus-to-supply-product-to-us-firm-sagent-from-gujarat-plant/90818651 Us Food And Drug Administration: Zydus to supply product to US firm Sagent from Gujarat plant,... Us Food And Drug Administration: The product is indicated for the short-term treatment of a breathing problem (Apnoea) in premature infants food and drug administration https://www.livemint.com/market/market-stats/zydus-wellness-q4-results-s0003672 Zydus Wellness Q4 Results 2026 - Find Zydus Wellness Q4 Earnings Result | ZYDUSWELL Q4 results ZYDUSWELL Q4 Results: Check out Zydus Wellness Q4 Result news, Zydus Wellness Q4 Earnings result updates and highlights. | ZYDUSWELL Q4 Results 2026 zydus wellness results find earnings https://www.livemint.com/market/stock-market-news/top-gainers-losers-on-april-06-zydus-wellness-trent-gravita-india-rbl-bank-bse-nmdc-among-top-gainers-11775468116701.html Top Gainers & Losers on April 06: Zydus Wellness, Trent, Gravita India, RBL Bank, BSE NMDC among... Apr 6, 2026 - On April 6, the Indian stock market reversed early losses, fueled by a ceasefire plan between Iran and the U.S. The Nifty 50 and Sensex each rose over 1%, with... https://manufacturing.economictimes.indiatimes.com/news/life-sciences/drl-zydus-recall-drugs-in-us-over-manufacturing-issues-usfda/124528349 DRL, Zydus recall drugs in US over manufacturing issues: USFDA, ETManufacturing Zydus Recall: Dr Reddy's is recalling muscle relaxant injections over stability testing failures, while Zydus Lifesciences is recalling antiviral medication... in us manufacturing issues drl zydus recall https://health.economictimes.indiatimes.com/news/pharma/zydus-cms-enter-pact-for-desidustat-in-greater-china/73434501 Zydus & CMS enter pact for Desidustat in Greater China, ETHealthworld The agreement is for Desidustat, a novel oral HIF-PH inhibitor for the treatment of anemia in patients with Chronic Kidney Disease (CKD) not-on-dialysis and... greater china zydus cms enter pact https://www.livemint.com/zydus-wellness/board-meetings/companyid-s0003672 Zydus Wellness Board Meetings | Board Meeting Dates of Zydus Wellness Zydus Wellness Board Meetings: Stay updated with the Board Meetings of Zydus Wellness. Access the latest Board Meeting Dates and valuable insights on Zydus... zydus wellness board meetings dates https://www.business-standard.com/article/companies/zydus-cadila-gets-usfda-nod-to-market-mineral-supplement-tablets-120091800444_1.html Zydus Cadila gets USFDA nod to market mineral supplement tablets | Company News - Business Standard Zydus Cadila said it has received approval from USFDA to market potassium chloride extended release tablets, a mineral supplement used to treat or prevent low... https://zydusmart.com/ ZydusMart by Zydus zydus https://www.prnewswire.com/in/news-releases/zydus-wellness-glucon-ds-energy-ka-gola-energizes-thousands-of-children-across-india-302490661.html Zydus Wellness' Glucon-D's 'Energy Ka Gola' energizes thousands of children across India /PRNewswire/ -- As Indian cities battled sweltering heatwaves this summer, Zydus Wellness' Glucon-D, India's most trusted glucose-based energy drink powder,... https://www.prnewswire.com/news-releases/zydus-therapeutics-reports-positive-topline-results-from-epics-iii-phase-2b3-trial-of-saroglitazar-magnesium-in-patients-with-primary-biliary-cholangitis-302542014.html Zydus Therapeutics Reports Positive Topline Results from EPICS-III Phase 2(b)/3 Trial of... /PRNewswire/ -- Zydus Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., a global innovation led healthcare company, today announced... https://hr.economictimes.indiatimes.com/news/industry/zydus-lifesciences-appoints-punit-patel-as-president-ceo-americas/104482366 Zydus Lifesciences appoints Punit Patel as President & CEO, Americas, ETHRWorld Before joining Zydus, he was the President of Red Oak Sourcing, leading the company's "multibillion-dollar generic portfolio", overseeing all aspects of Red... zydus lifesciences appoints punit patel president https://pharma.economictimes.indiatimes.com/news/pharma-industry/zydus-ties-up-with-synthon-bv-for-multiple-sclerosis-drug-launch-in-us/123709233 Zydus Lifesciences: Zydus ties up with Synthon BV for multiple sclerosis drug launch in US, ETPharma Zydus Lifesciences Global FZE has entered into an exclusive licensing and supply agreement with Synthon BV for Ozanimod capsules (a generic version of ZEPOSIA)... https://www.newswire.ca/news-releases/zydus-launches-worlds-first-biosimilar-of-adalimumab-516646601.html Zydus Launches World's First Biosimilar of Adalimumab /CNW/ - Access to this therapy will impact 12 million people suffering from auto immune disorders like rheumatoid arthritis, juvenile idiopathic arthritis,... zydus launches world first biosimilar https://www.benzinga.com/news/26/03/51152902/agenus-triggers-first-20m-contingent-payment-under-prior-collaboration-deal-with-zydus-lifesciences Agenus Triggers First $20M Contingent Payment Under Prior Collaboration Deal With Zydus... Mar 10, 2026 - Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that it has triggered the first $20 million contingent payment under its... https://www.business-standard.com/companies/news/zydus-lifesciences-gets-4-observations-from-usfda-for-gujarat-plant-124032700780_1.html Zydus Lifesciences gets 4 observations from USFDA for Gujarat plant | Company News - Business... Zydus Lifesciences on Wednesday said the US health regulator has issued a Form-483 with four observations following the inspection of its Ahmedabad-based SEZ... https://health.economictimes.indiatimes.com/tag/zydus+cadila+moraiya Zydus cadila moraiya - Latest zydus cadila moraiya , Information & Updates - Health -ET HealthWorld ETHealthworld.com brings latest zydus cadila moraiya news, views and updates from all top sources for the Indian Health industry. zydus cadila latest information moraiya updates health https://www.ded.uscourts.gov/opinion/astellas-pharma-inc-et-al-v-zydus-pharmaceuticals-usa-inc-et-al-0 Astellas Pharma Inc. et al v. Zydus Pharmaceuticals (USA) Inc. et al | District of Delaware |... astellas pharma et al https://legal.economictimes.indiatimes.com/news/international/astellas-wins-patent-validity-order-against-zydus-for-bladder-drug-myrbetriq/120388862 Astellas wins patent validity order against Zydus for bladder drug Myrbetriq, ETLegalWorld Astellas Pharma Inc. has won a key legal battle in the US, with a court upholding the validity of its patent for Myrbetriq, a sustained-release treatment for... https://www.financialexpress.com/about/zydus-lifesciences/ Zydus lifesciences News: Zydus lifesciences Latest News, Zydus lifesciences Today news, Zydus... Zydus lifesciences News: Check here latest news and updates about Zydus lifesciences in India. Read top headlines and breaking news today in India about Zydus... zydus lifesciences news latest today https://pharma.economictimes.indiatimes.com/news/drug-approvals-and-launches/zydus-innovative-anti-smoking-drug-approved-in-canada-a-breakthrough-for-smoking-cessation/123196491 Zydus' Innovative Anti-Smoking Drug Approved in Canada: A Breakthrough for Smoking Cessation,... Zydus Lifesciences has announced the approval of its anti-smoking drug ZDS-Varenicline by Health Canada, offering a new solution for smoking cessation without... anti smoking https://health.economictimes.indiatimes.com/news/pharma/zydus-lifesciences-gets-usfda-tentative-nod-for-two-generic-drugs/97951569 Zydus Lifesciences gets USFDA tentative nod for two generic drugs, ETHealthworld Zydus Lifesciences: Bosentan Tablet for oral suspension is indicated for the treatment of pulmonary arterial hypertension (PAH) in pediatric patients aged... zydus lifesciences for two generic drugs gets usfda https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-tentative-nod-from-usfda-to-market-diabetes-drug/78928067 Zydus Cadila gets tentative nod from USFDA to market diabetes drug, ETHealthworld Zydus Cadila: The company said the newly approved medication will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad. zydus cadila https://health.economictimes.indiatimes.com/news/pharma/usfda-grants-orphan-drug-designation-to-zydus-cadilas-saroglitazar-mg/80506195 Zydus Group: USFDA grants orphan drug designation to Zydus Cadila's Saroglitazar Mg, ETHealthworld Zydus Group: Zydus Cadila, which is a part of Cadila Group, said orphan drug designation provides eligibility for certain development incentives, including tax... orphan drug designation https://health.economictimes.indiatimes.com/tag/zydus+moraiya Zydus moraiya - Latest zydus moraiya , Information & Updates - Health -ET HealthWorld ETHealthworld.com brings latest zydus moraiya news, views and updates from all top sources for the Indian Health industry. latest information zydus moraiya updates health https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/zydus-completes-phase-iia-clinical-study-of-nlrp3-inhibitor-usnoflast-in-als-patients/113261273 Inflammatory Bowel Disease: Zydus completes Phase II(a) clinical study of NLRP3 inhibitor... Usnoflast (ZYIL1) is a novel, oral small molecule NLRP3 inhibitor. Studies have demonstrated that Usnoflast is highly potent in human whole blood assay and can... inflammatory bowel disease https://www.business-standard.com/amp/markets/news/zydus-life-up-2-on-usfda-nod-for-phase-ii-b-clinical-trial-for-usnoflast-125012000612_1.html Zydus Life up 2% on USFDA nod for Phase II(b) clinical trial for Usnoflast | News on Markets -... Zydus Life share rose after it received approval from USFDA to conduct Phase II(b) clinical trial for Usnoflast, a novel oral NLRP3 inflammasome inhibitor in... https://zyduslife.com/ Leading Global Pharmaceutical Company in India - Zydus group - Zydus Zydus Group, a leading Indian pharma company, offers global healthcare solutions from formulations and APIs to animal health and wellness products. global pharmaceutical company in india leading zydus group https://health.economictimes.indiatimes.com/news/pharma/zydus-lifesciences-gets-pas-approval-from-usfda-for-mycophenolate-mofetil/90345789 Zydus Lifesciences Limited: Zydus Lifesciences gets PAS approval from USFDA for Mycophenolate... Zydus Lifesciences Limited: Mycophenolate Mofetil is indicated for use in combination with other drugs i.e., cyclosporine and corticosteroids for the... zydus lifesciences limited gets pas approval https://health.economictimes.indiatimes.com/news/pharma/zydus-receives-usfda-tentative-nod-to-market-depressive-disorder-drug/97023646 Zydus Pharmaceuticals: Zydus receives USFDA tentative nod to market depressive disorder drug,... Zydus Pharmaceuticals: The approved drug levomilnacipran Extended-Release Capsules had annual sales of USD 85 million in the United States according to IQVIA... to market depressive disorder zydus pharmaceuticals receives https://www.ftc.gov/legal-library/browse/amicus-briefs/takeda-pharmaceutical-company-limited-et-al-v-zydus-pharmaceuticals-usa-inc-et-al Takeda Pharmaceutical Company Limited, et al. v. Zydus Pharmaceuticals (USA) Inc., et al. | Federal... Jun 7, 2018 - Brief of the Federal Trade Commission urging the District of New Jersey to reject argument that Hatch-Waxman patent infringement suits are categorically exempt... takeda pharmaceutical https://health.economictimes.indiatimes.com/news/pharma/zydus-receives-usfda-approval-for-lenalidomide-capsules/94173727 Zydus receives USFDA approval for Lenalidomide capsules, ETHealthworld Lenalidomide is used to treat various types of cancers and to treat anaemia in patients with certain blood/bone marrow disorders. The drug will be manufactured... lenalidomide capsules zydus receives usfda approval https://pharma.economictimes.indiatimes.com/news/financial-performance/zydus-lifesciences-to-introduce-semaglutide-variants-for-global-markets/123260909 Zydus Semaglutide Launch: Zydus Lifesciences to Introduce Semaglutide Variants for Global Markets,... Zydus Semaglutide Launch: Zydus Lifesciences plans to launch market-specific dosage strengths of Semaglutide, targeting regions including India, Canada, and... zydus semaglutide launch lifesciences introduce https://health.economictimes.indiatimes.com/tag/zydus+lifesciences+ltd. Zydus lifesciences ltd - Latest zydus lifesciences ltd , Information & Updates - Health -ET... ETHealthworld.com brings latest zydus lifesciences ltd news, views and updates from all top sources for the Indian Health industry. zydus lifesciences latest information ltd updates health https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-usfda-nod-for-antidepressant-drug/81210183 Zydus Cadila | USFDA: Zydus Cadila gets USFDA nod for antidepressant drug, ETHealthworld Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Nortriptyline Hydrochloride capsules USP, in... zydus cadila usfda gets nod antidepressant https://www.business-standard.com/amp/markets/news/stocks-to-watch-sbi-mankind-adani-enterprises-dr-reddy-s-zydus-life-124100300072_1.html Stocks To Watch: SBI, Mankind, Adani Enterprises, Dr. Reddy's, Zydus Life | News on Markets -... Stocks to watch: SBI plans to open 600 new branches this fiscal year to expand its reach in emerging residential areas, said its chairman and managing director... https://health.economictimes.indiatimes.com/news/pharma/zydus-acquires-6-stake-in-indian-biotech-company-mylab/101224840 Zydus acquires 6.5% equity stake in Indian biotech company Mylab, ETHealthworld Mylab's portfolio of in-vitro diagnostic kits covers cancer detection, blood safety, infectious diseases, genomics, veterinary Science and agro science. https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-launches-pill-for-prostate-cancer-patients/articleshow/107262997.cms Zydus launches pill for prostate cancer patients - The Economic Times The drug firm said the medication would cost Rs 6,995 per month, which is 50 per cent less than the currently available injectable options. "With this, the... prostate cancer zydus launches pill patients https://www.livemint.com/market/market-stats/zydus-wellness-q3-results-s0003672 Zydus Wellness Q3 Results 2026 - Find Zydus Wellness Q3 Earnings Result | ZYDUSWELL Q3 results ZYDUSWELL Q3 Results: Check out Zydus Wellness Q3 Result news, Zydus Wellness Q3 Earnings result updates and highlights. | ZYDUSWELL Q3 Results 2026 zydus wellness results find earnings https://cfo.economictimes.indiatimes.com/tag/zydus Zydus - Latest zydus , Information & Updates - CFO -ETCFO ETCFO.com brings latest zydus news, views and updates from all top sources for the Indian CFO industry. latest information zydus updates cfo https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/efforts-being-ramped-up-for-massive-production-of-vaccines-make-them-available-quickly-dbt-secretary/articleshow/82182341.cms Zydus Cadila: Efforts being ramped up for massive production of vaccines, make them available... Department of Biotechnology Secretary Renu Swarup said a financial support of Rs 400 crore is being provided to vaccine candidates from Zydus Cadilla,... https://www.businesswire.com/news/home/20240422114589/en/Zydus-launches-Mirabegron-Extended-Release-Tablets-in-the-US Zydus launches Mirabegron Extended-Release Tablets in the US Zydus Lifesciences Limited announces the launch of Mirabegron Extended-Release Tablets, 25 mg in the US market. extended release in the zydus launches mirabegron https://adisinsight.springer.com/drugs/800055423?error=cookies_not_supported&code=eea18929-35e1-4d63-90ce-47c5174c60cd Pertuzumab biosimilar - Zydus Cadila - AdisInsight ZRC 3277 is a biosimilar version of pertuzumab [see AdisInsight drug profile 800014629], being developed by Zydus Cadila, for the treatment of breast cancer, zydus cadila pertuzumab biosimilar adisinsight